Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical drug investigation

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40261-017-0601-5PMID 29185238
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antidepressant-Induced Acute Liver Injury: A Case–Control Study in an Italian Inpatient Population

  2017cited by this paper
• The Impact of the Educational Intervention on Knowledge, Attitude, and Practice of Pharmacovigilance toward Adverse Drug Reactions Reporting among Health-care Professionals in a Tertiary Care Hospital in South India

  2017cited by this paper
• Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.

  2017cited by this paper
• Drug-induced liver injury: recent advances in diagnosis and risk assessment

  2017cited by this paper
• Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.

  2017cited by this paper
• Measuring inter-rater reliability for nominal data – which coefficients and confidence intervals are appropriate?

  2016cited by this paper
• RUCAM in Drug and Herb Induced Liver Injury: The Update

  2015cited by this paper
• Pattern of Adverse Drug Reactions Reported with Cardiovascular Drugs in a Tertiary Care Teaching Hospital.

  2015cited by this paper
• Factors affecting the development of adverse drug reactions (Review article).

  2014cited by this paper
• Causality assessment of adverse drug reactions

  2014cited by this paper
• Causality Assessment for Suspected DILI During Clinical Phases of Drug Development

  2014cited by this paper
• Signal Detection of Potentially Drug-Induced Acute Liver Injury in Children Using a Multi-Country Healthcare Database Network

  2014cited by this paper
• Causality assessment: Which is best—expert opinion or RUCAM?

  2014cited by this paper
• Herbal hepatotoxicity: suspected cases assessed for alternative causes

  2013cited by this paper
• Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?

  2013cited by this paper
• A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record Databases

  2012cited by this paper
• Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis

  2012cited by this paper
• Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?

  2011cited by this paper
• Adverse drug reaction and causality assessment scales

  2011cited by this paper
• Causality assessment methods in drug induced liver injury: strengths and weaknesses.

  2011cited by this paper
• Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity

  2011cited by this paper
• Drug‐induced acute liver failure: Results of a U.S. multicenter, prospective study

  2010cited by this paper
• 1137 THE HLA CLASS I B*1801 ALLELE INFLUENCES HEPATOCELLULAR EXPRESSION OF AMOXICILLIN-CLAVULANATE LIVER DAMAGE AND OUTCOME IN SPANISH PATIENTS

  2010cited by this paper
• Epidemiology of idiosyncratic drug-induced liver injury.

  2009cited by this paper
• Biomarkers for the Diagnosis and Management of Drug-Induced Liver Injury

  2009cited by this paper
• The new Sentinel Network--improving the evidence of medical-product safety.

  2009cited by this paper
• Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug‐induced liver injury

  2008cited by this paper
• Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug‐induced liver injury

  2008cited by this paper
• Practical guidelines for diagnosis and early management of drug-induced liver injury.

  2008cited by this paper
• Data mining for signals in spontaneous reporting databases: proceed with caution

  2007cited by this paper
• Causality assessment of drug-induced hepatotoxicity: promises and pitfalls.

  2007cited by this paper
• Drug-related hepatotoxicity.

  2006cited by this paper
• Idiosyncratic drug hepatotoxicity

  2005cited by this paper
• Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel

  2005cited by this paper
• Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.

  2005cited by this paper
• Is the Naranjo Probability Scale Accurate Enough to Ascertain Causality in Drug-Induced Hepatotoxicity?

  2004cited by this paper
• Validity study of a new diagnostic scale for drug-induced liver injury in Japan-comparison with two previous scales.

  2004cited by this paper
• Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting.

  2003cited by this paper
• Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

  2002cited by this paper
• Comparison of two clinical scales for causality assessment in hepatotoxicity

  2001cited by this paper
• Accuracy of hepatic adverse drug reaction reporting in one English health region

  1999cited by this paper
• Causal or Casual?

  1997cited by this paper
• Development and validation of a clinical scale for the diagnosis of drug‐induced hepatitis

  1997cited by this paper
• Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

  1993cited by this paper
• Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.

  1993cited by this paper
• Assessing methods for causality assessment of suspected adverse drug reactions.

  1989cited by this paper
• Goodman and Gilman's the Pharmacological Basis of Therapeutics

  1986cited by this paper
• The Food and Drug Administration Algorithm: Special Workshop—Regulatory

  1984cited by this paper
• Basic and Clinical Pharmacology

  1982cited by this paper
• A method for estimating the probability of adverse drug reactions

  1981cited by this paper
• Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit.

  1968cited by this paper
• Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit.

  1968cited by this paper
• The Pharmacological Basis of Therapeutics

  1941cited by this paper

• Potential use of serum microvesicle indicators to distinguish different types of drug-induced liver injury.

  2025cites this paper
• Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease

  2023cites this paper
• Daño hepático inducido por medicamentos: relación entre el índice R y la histopatología

  2022cites this paper
• Drug-induced liver injury: Relation between the R ratio and histopathology.

  2022cites this paper
• Agreement among different scales for causality assessment in drug-induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

  2021cites this paper
• CAUSALITY IMPUTATION BETWEEN HERBAL PRODUCTS AND HILI: AN ALGORITHM EVALUATION IN A SYSTEMATIC REVIEW.

  2021cites this paper
• Sports nutrition supplements and adverse events – a meta-epidemiological study of case reports specifically addressing causality assessment

  2021cites this paper
• Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department

  2020cites this paper
• Drug Hepatotoxicity: Causality Assessment.

  2020cites this paper
• Alanine transaminase and hemoglobin appear to predict the occurrence of antituberculosis medication hepatotoxicity; findings and implications in Botswana

  2020cites this paper
• Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis

  2020cites this paper
• Comparison of diagnostic accuracy of 3 diagnostic criteria combined with refined pathological scoring system for drug-induced liver injury

  2020cites this paper
• Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Professionals working in Primary, Secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria

  2020cites this paper
• Comparing the accuracy of three diagnostic criteria and a refined pathological scoring system in drug-induced liver injury: From suspected to definite

  2019cites this paper
• Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019

  2019cites this paper
• Pharmacovigilance - The next chapter.

  2019cites this paper
• Hepatotoxicity; Drug-Induced Liver Injury

  2019cites this paper
• Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future

  2019cites this paper